Literature DB >> 9473460

Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.

R A Robinson1, W H Burgess, S U Emerson, R S Leibowitz, S A Sosnovtseva, S Tsarev, R H Purcell.   

Abstract

The hepatitis E virus (HEV) capsid antigen has been proposed as a candidate subunit vaccine for the prevention of hepatitis E. The full-length HEV ORF2 protein product is predicted to contain 660 amino acids and to weigh 72,000 daltons. Expression of the HEV ORF2 capsid gene from recombinant baculoviruses in insect cells produced multiple immunoreactive proteins ranging in size from 30 to 100 kDa. The most abundant HEV proteins had molecular weights of 72, 63, 56, and 53 kDa. Temporal expression kinetics of these viral polypeptides indicated that the 72- and 63-kDa polypeptides were produced abundantly within the initial 36 h. postinfection but were replaced by 56- and 53-kDa polypeptides in the cell and medium, respectively, by 48 h postinfection. The 53-kDa protein was secreted as early as 24 h. postinfection, and accumulation in the medium peaked by 72 h postinfection. Purification of the 53-, 56-, and 63-kDa viral polypeptides was accomplished by anion-exchange and subsequent gel filtration chromatography. Sequence analysis of the 53-, 56-, and 63-kDa HEV polypeptides indicated that the amino terminus was amino acid residue 112 of the predicted full-length protein product. The results of carboxy terminal amino acid sequencing indicated that the carboxy terminus of the 53-, 56-, and 63-kDa HEV proteins was located at amino acid residues 578, 607, and 660, respectively. The molecular masses of the 53- and 56-kDa HEV polypeptides were 53,872 and 56,144 as determined by mass spectroscopy. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473460     DOI: 10.1006/prep.1997.0817

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  56 in total

1.  Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Authors:  M A Riddell; F Li; D A Anderson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 3.  Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.

Authors:  Xiao Zhang; Lu Xin; Shaowei Li; Mujin Fang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA.

Authors:  J D Easterbrook; J B Kaplan; N B Vanasco; W K Reeves; R H Purcell; M Y Kosoy; G E Glass; J Watson; S L Klein
Journal:  Epidemiol Infect       Date:  2007-01-15       Impact factor: 2.451

Review 5.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

6.  Hepatitis E vaccine.

Authors:  Rakesh Aggarwal; Shahid Jameel
Journal:  Hepatol Int       Date:  2008-04-10       Impact factor: 6.047

7.  Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.

Authors:  D J Schofield; J Glamann; S U Emerson; R H Purcell
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.

Authors:  Tian-Cheng Li; Naokazu Takeda; Tatsuo Miyamura; Yoshiharu Matsuura; Joseph C Y Wang; Helena Engvall; Lena Hammar; Li Xing; R Holland Cheng
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 9.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M.

Authors:  Jitvimol Seriwatana; Mrigendra P Shrestha; Robert M Scott; Sergei A Tsarev; David W Vaughn; Khin Saw Aye Myint; Bruce L Innis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.